Bundgaard H, von Oettingen G, Larsen K M, Landsfeldt U, Jensen K A, Nielsen E, Cold G E
Department of Neuroanaesthesiology, Aarhus University Hospital, Denmark.
Acta Anaesthesiol Scand. 1998 Jul;42(6):621-7. doi: 10.1111/j.1399-6576.1998.tb05292.x.
Studies concerning the cerebrovascular effects of sevoflurane in patients with space-occupying lesions are few. This study was carried out as a dose-response study comparing the effects of increasing sevoflurane concentration (1.5% (0.7 MAC) to 2.5% (1.3 MAC)) on cerebral blood flow (CBF), intracranial pressure (ICP), cerebrovascular resistance (CVR), metabolic rate of oxygen (CMRO2) and CO2-reactivity in patients subjected to craniotomy for supratentorial brain tumours.
Anaesthesia was induced with propofol/fentanyl/atracurium and maintained with 1.5% sevoflurane in air/oxygen at normocapnia. Blood pressure was maintained constant by ephedrine. In group 1 (n = 10), the patients received continuously 1.5% sevoflurane. Subdural ICP, CBF and CMRO2 were measured twice at 30-min intervals. In group 2 (n = 10), sevoflurane concentration was increased from 1.5% to 2.5% after CBF1. CBF2 was measured after 20 min during 2.5% sevoflurane. Finally, CO2-reactivity was studied in both groups.
In group 1, no time-dependent alterations in CBF, CVR, ICP and CMRO2 were found. In group 2, an increase in sevoflurane from 1.5% to 2.5% resulted in an increase in CBF from 29 +/- 10 to 34 +/- 12 ml 100 g-1 min-1 and a decrease in CVR from 2.7 +/- 0.9 to 2.3 +/- 1.2 mmHg ml-1 min 100 g (P < 0.05), while ICP and CMRO2 were unchanged. CO2-reactivity was maintained at 1.5% and 2.5% sevoflurane.
Sevoflurane is a cerebral vasodilator in patients with cerebral tumours. Sevoflurane increases CBF and decreases CVR in a dose-dependent manner. CO2-reactivity is preserved during 1.5% and 2.5% sevoflurane.
关于七氟醚对占位性病变患者脑血管影响的研究较少。本研究作为一项剂量反应研究,比较了七氟醚浓度增加(从1.5%(0.7MAC)至2.5%(1.3MAC))对幕上脑肿瘤开颅手术患者脑血流量(CBF)、颅内压(ICP)、脑血管阻力(CVR)、氧代谢率(CMRO2)和二氧化碳反应性的影响。
采用丙泊酚/芬太尼/阿曲库铵诱导麻醉,在正常二氧化碳分压下以1.5%七氟醚维持于空气/氧气混合气体中。通过麻黄碱维持血压恒定。在第1组(n = 10)中,患者持续接受1.5%七氟醚。硬膜下ICP、CBF和CMRO2每隔30分钟测量两次。在第2组(n = 10)中,在CBF1测量后七氟醚浓度从1.5%增加至2.5%。在2.5%七氟醚期间20分钟后测量CBF2。最后,在两组中研究二氧化碳反应性。
在第1组中,未发现CBF、CVR、ICP和CMRO2随时间的变化。在第2组中,七氟醚从1.5%增加至2.5%导致CBF从29±10增加至34±12 ml 100g-1 min-1,CVR从2.7±0.9降至2.3±1.2 mmHg ml-1 min 100g(P < 0.05),而ICP和CMRO2未改变。在1.5%和2.5%七氟醚时二氧化碳反应性得以维持。
七氟醚是脑肿瘤患者的脑血管扩张剂。七氟醚以剂量依赖方式增加CBF并降低CVR。在1.5%和2.5%七氟醚期间二氧化碳反应性得以保留。